In clinical pharmacology studies using the therapeutic dosage regimen of 100 mg followed by 50 mg q12h, serum tigecycline steady-state Cmax was 866±233 ng/ ml for 30-minute infusions and 634±97 ng/ ml for 60-minute infusions.